The USA has long collaborated with the Ugandan government to address public health challenges, particularly in the fight against HIV/AIDS.
Through initiatives like the President’s Emergency Plan for AIDS Relief (PEPFAR), the U.S. has provided critical resources and expertise to help Uganda curb the spread of HIV, improve access to treatment, and reduce the stigma associated with the disease.
This partnership has saved countless lives, particularly in high-prevalence regions like Rakai, where the first cases of HIV were identified in the 1980s.
Recently, the U.S. government renewed its commitment to this fight, pledging continued support for Uganda’s HIV/AIDS response efforts.
During a visit to the Rakai Health Sciences Program (RHSP), U.S. Ambassador to Uganda William W. Popp praised the centre’s groundbreaking research in HIV/AIDS and infectious diseases.
The ambassador highlighted the essential role that RHSP plays in developing preventive measures and improving treatment accessibility, assuring that the U.S. would remain a steadfast partner in supporting Uganda’s health programs.
According to Ambassador Popp, the U.S. has worked in Uganda for over 20 years through partnerships that have greatly reduced the spread of HIV.
In some communities, HIV rates were as high as 30%, but with efforts like testing, prevention programs, and treatment using Antiretroviral (ARV) medicines, those numbers have dropped significantly.
Popp explained that the next goal is to make long-lasting injectable versions of PrEP (pre-exposure prophylaxis) more widely available.
Although they are still in the early stages of figuring out how to bring more of these treatments to Uganda and the rest of the world, challenges like cost remain.
He further urged people who are living with HIV to continue using the available treatment options that are already accessible.
“Even when we work towards long-term injectable solutions, utilising PREP that is available that has been made through PEPFAR Program, let’s ensure people know their status, and if they are HIV positive let them take Antiretroviral (ARVs) medicines, to suppress their viral loads, so that they are not transmitting it to other people, that is something we shall continue to support and its combination of factors we are going to continue to work on to boost the fight against HIV/AIDS” he added.
Over 1.4 million people in Uganda are currently receiving free Antiretroviral (ARV) treatment through the PEPFAR (U.S. President’s Emergency Plan for AIDS Relief) program.
Each year, the United States invests over $500 million in Uganda’s health sector, with a primary focus on fighting HIV/AIDS, but also working to prevent diseases like malaria, tuberculosis, and others.
Ambassador Popp stressed the need to shift more efforts toward vulnerable groups, especially young people, who continue to face higher HIV rates.
He stressed the importance of ensuring that young people know their HIV status, receive proper counselling, starts taking ARVs, and stay on treatment.
These steps, he noted, are essential to reaching the 2030 goal: 95% of people knowing their status, taking ARVs, and suppressing their viral loads.
Dr. Edward Nelson Kankaka, a research scientist at RHSP, told the ambassador about ongoing research aimed at finding a cure for HIV.
The team is studying how the virus hides in the body, with the hope of either forcing it out or keeping it permanently dormant.
Dr. Ronald Moses Galiwango, another researcher, discussed progress in their studies on safe male circumcision and other important health initiatives.
During his visit, Ambassador Popp toured community outreach programs and laboratories at RHSP. The U.S. remains the largest provider of health assistance to Uganda, where approximately 1.35 million people are living with HIV.
Since 2004, PEPFAR has invested nearly $4.5 billion in strengthening Uganda’s ability to fight HIV/AIDS and improve overall healthcare.
Founded in 1987 as the Rakai Project, the Rakai Health Sciences Program (RHSP) has been at the forefront of research aimed at combating the HIV epidemic.
Over the years, RHSP has made significant strides in developing interventions that address the spread and impact of HIV in Uganda.
Much of its success is due to substantial support from the U.S. National Institutes of Health (NIH) and the U.S. Centers for Disease Control and Prevention (CDC) through the PEPFAR program.
This collaboration has enabled RHSP to conduct high-impact research and implement effective public health strategies in the fight against HIV/AIDS.
END
English 